Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2010
12/30/2010US20100330180 Tabletting process
12/30/2010US20100330179 Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer
12/30/2010US20100330178 Extended release compositions comprising as active compound venlafaxine hydrochloride
12/30/2010US20100330177 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
12/30/2010US20100330176 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
12/30/2010US20100330175 Cross-linked polyallylamine tablet core
12/30/2010US20100330174 Betaine compositions
12/30/2010US20100330173 Compounds and methods for treating influenza
12/30/2010US20100330172 Controlled-release pharmaceutical formulation
12/30/2010US20100330171 Dietary Supplement for Eye Health
12/30/2010US20100330170 Flavored Vegetarian Cellulose Capsule and Methods for Producing said Capsule
12/30/2010US20100330169 Pharmaceutical Tablet Containing A Liquid Filled Capsule
12/30/2010US20100330168 Pharmaceutical composition based on micronized progesterone and uses thereof
12/30/2010US20100330167 Nanoparticles for protein drug delivery
12/30/2010US20100330166 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation
12/30/2010US20100330165 Use of chemotherapeutic agents
12/30/2010US20100330164 Method of increasing tear production with purinergic receptor agonists
12/30/2010US20100330163 Compositions and Methods for Enhancing Metal Ion Dependent Drug Therapies
12/30/2010US20100330162 Spray freeze dry of compositions for pulmonary adminstration
12/30/2010US20100330161 Oral delivery of tetanus toxoid
12/30/2010US20100330160 Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6
12/30/2010US20100330159 System for transporting active substances in a biological system
12/30/2010US20100330158 Protein-assisted drug delivery system for the targeted administration of active agents
12/30/2010US20100330157 Biomaterial for the controlled delivery of ingredients
12/30/2010US20100330156 Phenazine derivatives and uses thereof
12/30/2010US20100330155 METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA
12/30/2010US20100330154 amphoteric liposomes comprising neutral lipids
12/30/2010US20100330153 Method for producing biologically ingestible material and biologically ingestible material obtained therefrom
12/30/2010US20100330152 Methods and compositons for antisense vegf oligonucleotides
12/30/2010US20100330151 Method of Promoting Gastrointestinal Health Using a Combination of a Probiotic Microorganism and Chocolate
12/30/2010US20100330150 Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs
12/30/2010US20100330149 Solid Drug Tablets for Implantable Drug Delivery Devices
12/30/2010US20100330147 Drug Delivery Compositions Including Nanoshells For Triggered Drug Release
12/30/2010US20100330141 Product for absorption purposes
12/30/2010US20100330137 High bioavailability formulation of mangosteen and manufacturing process thereof
12/30/2010US20100330131 Minocycline oral dosage forms for the treatment of acne
12/30/2010US20100330130 Substantially pure imatinib or a pharmaceutically acceptable salt thereof
12/30/2010US20100330129 Gastroresistant Pharmaceutical Formulations Containing Rifaximin
12/30/2010US20100330002 Compositions and methods comprising basic amino acid peptides and proteases
12/30/2010US20100330001 Antibacterial compositions
12/30/2010US20100330000 Enzymes for treatment of gingivitis
12/30/2010US20100329999 Antiperspirant Aerosol Composition
12/30/2010US20100329998 Novel heterocycles
12/30/2010US20100329997 Use of creatine or creatine compounds for skin preservation
12/30/2010US20100329996 Novel Combination of Therapeutic Agents
12/30/2010US20100329995 Compositions containing lactoferrin, and methods of using same to promote growth of skin cells
12/30/2010US20100329994 Use of Deuterium Dioxide for Treating Hyperproliferative Skin Diseases
12/30/2010US20100329984 Respiratory dispersion for metered dose inhalers
12/30/2010US20100329982 Particles with inducible change of shape
12/30/2010US20100329981 Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
12/30/2010US20100329976 Nanoparticulate compositions of angiogenesis inhibitors
12/30/2010US20100326437 Inhalable medicament
12/30/2010DE102009027151A1 Partikel mit induzierbarer Formänderung Particles with inducible strain
12/29/2010WO2010151896A1 Solid drug tablets for implantable drug delivery devices
12/29/2010WO2010151893A1 Implantable drug delivery devices and methods of making the same
12/29/2010WO2010151778A2 Topical compositions and methods for wound care
12/29/2010WO2010151746A2 Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
12/29/2010WO2010151745A1 Oral dosage forms
12/29/2010WO2010151565A2 Combination therapies for the treatment of obesity
12/29/2010WO2010151353A2 Injectable beta-hairpin peptide hydrogel that kills methicillin-resistant staphylococcus aureus
12/29/2010WO2010151338A2 Myostatin inhibitor enhancement of musculoskeletal repair
12/29/2010WO2010151281A1 Methods and kits for treating joints and soft tissues
12/29/2010WO2010151275A1 Chewable drug
12/29/2010WO2010151269A1 Para-xylylene based multilayer drug elution devices
12/29/2010WO2010151241A1 Topical composition containing naproxen
12/29/2010WO2010151240A1 Topical composition containing ibuprofen
12/29/2010WO2010151216A1 Method for treating a patient at risk for developing an nsaid-associated ulcer
12/29/2010WO2010151173A1 Nano-dispersed composition containing coenzyme q10 and method for producing same
12/29/2010WO2010151150A2 Formulations for vertebrate pest control
12/29/2010WO2010151104A1 An emulsion system derives from engkabang fat esters
12/29/2010WO2010151080A2 Pharmaceutical composition containing carboxylosartan and a production method therefor
12/29/2010WO2010151020A2 Fast-dissolving oral film for effectively concealing unpleasant tastes
12/29/2010WO2010151005A2 Injectable composition containing hydroxychloroquine for local administration for treating cancer
12/29/2010WO2010151004A2 Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids
12/29/2010WO2010150984A2 Amorphous adefovir dipivoxil solid dispersion with improved stability, and method for preparing same
12/29/2010WO2010150982A2 Recombinant hemagglutinin protein having superior biocompatibility for an influenza virus vaccine, and method for preparing biodegradable plga microspheres containing same
12/29/2010WO2010150930A1 Fast dissolving film for oral administration which prevents unpleasant taste effectively
12/29/2010WO2010150378A1 Ophthalmic composition
12/29/2010WO2010150262A2 Reverse hexagonal mesophases (hii) and uses thereof
12/29/2010WO2010150261A1 A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
12/29/2010WO2010150221A1 Taste masked pharmaceutical compositions of pregabalin
12/29/2010WO2010150219A1 Pharmaceutical composition of duloxetine or pharmaceutically acceptable salts thereof
12/29/2010WO2010150144A2 Low dose pharmaceutical compositions of celecoxib
12/29/2010WO2010150127A1 Glucosamine formulations
12/29/2010WO2010150051A1 Composition for cosmetic, pharmaceutical or dietary applications
12/29/2010WO2010150036A1 Sol-gel nanostructured and biocompatible platinum-titania and platinum- silica biocatalysts nanostructured and biocompatible for use in cancer treatment
12/29/2010WO2010149794A2 Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane)
12/29/2010WO2010149785A1 Cationic liposomes for the delivery of high molecular weight compounds
12/29/2010WO2010149734A1 Cannula assembly for co-delivery of medicaments
12/29/2010WO2010149727A2 Injectable formulations containing asenapine and method of treatment using same
12/29/2010WO2010149363A2 A pharmaceutical composition
12/29/2010WO2010149230A1 Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane) hydrochloride
12/29/2010WO2010149215A1 Artesunate pharmaceutical compositions soluble in aqueous solutions
12/29/2010WO2010149196A1 Taste masked dosage form of pharmaceutically acceptable salt of escitalopram
12/29/2010WO2010149183A1 Aprepitant in the form of a solid solution
12/29/2010WO2010149169A2 Controlled release formulations
12/29/2010WO2010148653A1 Polymer vesicles of asymmetric membrane
12/29/2010WO2010148572A1 Method for treating or ameliorating mucocutaneous or ocular toxicities
12/29/2010WO2010148533A1 A pharmaceutical composition with the effect of treating diabetes
12/29/2010WO2010122474A3 A medicinal antifungal and steroid cream incorporating a biopolymer and a process to make it
1 ... 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 ... 2991